Article Details
Retrieved on: 2021-05-06 16:16:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“Neoadjuvant chemotherapy plus monoclonal antibodies against HER2 should be considered to be the standard of care for early-stage patients, and ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here